Evidence map›Paper›PMID 38715048›Full record

ArticleClinical epigenetics2024

Epigenetics of the non-coding RNA nc886 across blood, adipose tissue and skeletal muscle in offspring exposed to diabetes in pregnancy.

Line Hjort, Sandra Stokholm Bredgaard, Eleonora Manitta, Irene Marques, Anja Elaine Sørensen, David Martino, Louise Groth Grunnet, Louise Kelstrup, Azadeh Houshmand-Oeregaard, Tine Dalsgaard Clausen and 7 more

Abstract read
In one paragraph

Article in Clinical epigenetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Line HjortNovo Nordisk Foundation Center for Basic Metabolic Research, Metabolic Epigenetics Group, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. line.hjort@sund.ku.dk.
Sandra Stokholm BredgaardDepartment of Science and Environment, Roskilde University, Roskilde, Denmark.
Eleonora ManittaNovo Nordisk Foundation Center for Basic Metabolic Research, Metabolic Epigenetics Group, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Irene MarquesCenter for Pregnant Women With Diabetes, Department of Obstetrics, Rigshospitalet, Copenhagen, Denmark.
Anja Elaine SørensenDepartment of Science and Environment, Roskilde University, Roskilde, Denmark.
David MartinoMurdoch Children's Research Institute, Parkville, Melbourne, VIC, Australia.
Louise Groth GrunnetClinical Research, Steno Diabetes Center Copenhagen, Herlev Hospital, Herlev, Denmark.
Louise KelstrupCenter for Pregnant Women With Diabetes, Department of Obstetrics, Rigshospitalet, Copenhagen, Denmark.
Azadeh Houshmand-OeregaardCenter for Pregnant Women With Diabetes, Department of Obstetrics, Rigshospitalet, Copenhagen, Denmark.
Tine Dalsgaard ClausenCenter for Pregnant Women With Diabetes, Department of Obstetrics, Rigshospitalet, Copenhagen, Denmark.
Elisabeth Reinhardt MathiesenCenter for Pregnant Women With Diabetes, Department of Obstetrics, Rigshospitalet, Copenhagen, Denmark.
Sjurdur Frodi OlsenCentre for Fetal Programming, Statens Serum Institut, Copenhagen, Denmark.
Richard SafferyMurdoch Children's Research Institute, Parkville, Melbourne, VIC, Australia.
Romain BarrèsNovo Nordisk Foundation Center for Basic Metabolic Research, Metabolic Epigenetics Group, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Peter DammCenter for Pregnant Women With Diabetes, Department of Obstetrics, Rigshospitalet, Copenhagen, Denmark.
Allan Arthur VaagClinical Research, Steno Diabetes Center Copenhagen, Herlev Hospital, Herlev, Denmark.
Louise Torp DalgaardDepartment of Science and Environment, Roskilde University, Roskilde, Denmark. ltd@ruc.dk.

Funding

Novo Nordisk Fonden NNF17SA0031406Novo Nordisk Foundation Center for Basic Metabolic Research NNF18CC0034900The Innovation Fund Denmark 09-067124
6 · The paper itself

Abstract

backgroundDiabetes in pregnancy is associated with increased risk of long-term metabolic disease in the offspring, potentially mediated by in utero epigenetic variation. Previously, we identified multiple differentially methylated single CpG sites in offspring of women with gestational diabetes mellitus (GDM), but whether stretches of differentially methylated regions (DMRs) can also be identified in adolescent GDM offspring is unknown. Here, we investigate which DNA regions in adolescent offspring are differentially methylated in blood by exposure to diabetes in pregnancy. The secondary aim was to characterize the RNA expression of the identified DMR, which contained the nc886 non-coding RNA.

methodsTo identify DMRs, we employed the bump hunter method in samples from young (9-16 yr, n = 92) offspring of women with GDM (O-GDM) and control offspring (n = 94). Validation by pyrosequencing was performed in an adult offspring cohort (age 28-33 years) consisting of O-GDM (n = 82), offspring exposed to maternal type 1 diabetes (O-T1D, n = 67) and control offspring (O-BP, n = 57). RNA-expression was measured using RT-qPCR in subcutaneous adipose tissue and skeletal muscle.

resultsOne significant DMR represented by 10 CpGs with a bimodal methylation pattern was identified, located in the nc886/VTRNA2-1 non-coding RNA gene. Low methylation status across all CpGs of the nc886 in the young offspring was associated with maternal GDM. While low methylation degree in adult offspring in blood, adipose tissue, and skeletal muscle was not associated with maternal GDM, adipose tissue nc886 expression was increased in O-GDM compared to O-BP, but not in O-T1D. In addition, adipose tissue nc886 expression levels were positively associated with maternal pre-pregnancy BMI (p = 0.006), but not with the offspring's own adiposity.

conclusionsOur results highlight that nc886 is a metastable epiallele, whose methylation in young offspring is negatively correlated with maternal obesity and GDM status. The physiological effect of nc886 may be more important in adipose tissue than in skeletal muscle. Further research should aim to investigate how nc886 regulation in adipose tissue by exposure to GDM may contribute to development of metabolic disease.

Indexed as

Adipose TissueDiabetes, GestationalDNA MethylationEpigenesis, GeneticMuscle, SkeletalPrenatal Exposure Delayed EffectsAdolescentAdultChildCpG IslandsDiabetes Mellitus, Type 1FemaleHumansMalePregnancyRNA, Long NoncodingRNA, Long NoncodingRNA, UntranslatedAdiposeDevelopmental programmingDNA methylationEpigeneticsGene expressionGestational diabetesIntrauterine hyperglycemiaMusclenc886ncRNAType 1 diabetesVTRNA2-1

Identifiers

PMID38715048
PMCPMC11077860

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.